Premium
GH Research PLC (GHRS)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | Institution | 10 763 288 | 15,69% | US$ 289,32M | 2026-03-31 |
| BVF Partners L.P. | Institution | 8 650 158 | 12,61% | US$ 232,52M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 7 676 697 | 11,19% | US$ 206,35M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 6 753 031 | 9,84% | US$ 181,52M | 2025-03-31 |
| Lynx1 Master Fund LP | Institution | 6 353 069 | 9,26% | US$ 170,77M | 2025-02-06 |
| RTW Investments, LP | Institution | 5 933 815 | 8,65% | US$ 159,50M | 2026-03-31 |
| FMR LLC | Institution | 5 136 045 | 7,49% | US$ 138,06M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 4 599 019 | 6,70% | US$ 123,62M | 2025-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 3 605 399 | 5,26% | US$ 96,91M | 2025-03-31 |
| Avoro Capital Advisors LLC | Institution | 1 800 000 | 2,62% | US$ 48,38M | 2026-03-31 |
| The Toronto-Dominion Bank | Institution | 1 397 873 | 2,04% | US$ 37,57M | 2026-03-31 |
| Troluce Capital Advisors, LLC | Institution | 990 472 | 1,44% | US$ 26,62M | 2026-03-31 |
| Millennium Management LLC | Institution | 937 898 | 1,37% | US$ 25,21M | 2026-03-31 |
| Jefferies Financial Group Inc. | Institution | 712 300 | 1,04% | US$ 19,15M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 619 881 | 0,90% | US$ 16,66M | 2025-03-31 |
| 5AM Venture Management, LLC | Institution | 572 665 | 0,83% | US$ 15,39M | 2026-03-31 |
| BlackRock, Inc. | Institution | 455 618 | 0,66% | US$ 12,25M | 2026-03-31 |
| UBS Asset Management AG | Institution | 412 416 | 0,60% | US$ 11,09M | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 325 000 | 0,47% | US$ 8,74M | 2026-03-31 |
| Foresite Capital Management, LLC | Institution | 315 492 | 0,46% | US$ 8,48M | 2026-03-31 |
| Boothbay Fund Management, LLC | Institution | 282 891 | 0,41% | US$ 7,60M | 2026-03-31 |
| Centerbook Partners LP | Institution | 216 574 | 0,32% | US$ 5,82M | 2026-03-31 |
| HighVista Strategies LLC | Institution | 213 212 | 0,31% | US$ 5,73M | 2026-03-31 |
| RA Capital Nexus Fund II, L.P. | Institution | 191 617 | 0,28% | US$ 5,15M | 2025-03-31 |
| Marshall Wace LLP | Institution | 91 108 | 0,13% | US$ 2,45M | 2026-03-31 |
| Occam Crest Management LP | Institution | 80 000 | 0,12% | US$ 2,15M | 2026-03-31 |
| Arrow Capital Management Inc. | Institution | 77 000 | 0,11% | US$ 2,07M | 2025-12-31 |
| Trexquant Investment LP | Institution | 69 808 | 0,10% | US$ 1,88M | 2026-03-31 |
| AdvisorShares Investments, LLC | Institution | 67 034 | 0,10% | US$ 1,80M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 65 464 | 0,10% | US$ 1,76M | 2026-03-31 |
| XTX Markets Limited | Institution | 52 090 | 0,08% | US$ 1,40M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 44 795 | 0,07% | US$ 1,20M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 40 483 | 0,06% | US$ 1,09M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 32 685 | 0,05% | US$ 878,57k | 2026-03-31 |
| Diadema Partners LP | Institution | 26 836 | 0,04% | US$ 721,35k | 2026-03-31 |
| Marathon Asset Management Limited | Institution | 24 077 | 0,04% | US$ 647,19k | 2026-03-31 |
| Morgan Stanley | Institution | 21 325 | 0,03% | US$ 573,22k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
